Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma

NCT05228808 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05228808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05228808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Immunohistochemical Expression of PD-L1 in Pancreatic Ductal Adenocarcinoma
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
February 1, 2022
Completion date
December 1, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma